iShares Biotechnology ETF (IBB)
NasdaqGM: IBB
· Real-Time Price · USD
212.02
+2.97 (1.42%)
At close: Sep 01, 2026, 3:59 PM
The price, the headline numbers and the latest news, in one place.
iShares Biotechnology ETF (IBB) Stock Price, Analysis & Data
1.42% (1D)
| Bid | 185.09 |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| 0.00 | |
| n/a | |
| 27.5 | |
| n/a | |
| P/B (ttm) | 1.31 |
| P/S (ttm) | 0.00 |
| Earnings Date | n/a |
| Ask | 197.12 |
| Volume | 1,562,439 |
| Avg. Volume (20D) | 1,592,922 |
| Open | 208.74 |
| Previous Close | 209.05 |
| Day's Range | 208.47 - 210.85 |
| 52-Week Range | 138.79 - 217.12 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About IBB
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified....
Industry n/a
Sector n/a
IPO Date Feb 12, 2001
Employees n/a
Stock Exchange NasdaqGM
Ticker Symbol IBB
Financial Performance
In undefined, iShares Biotechnology ETF's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.
Financial StatementsEarnings Surprise
iShares Biotechnology ETF has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.
Page 1 of 2